China Pharma Holdings earnings were -$4.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CPHI earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$1.2M, up 9.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CPHI reported annual earnings of -$4.7M, with 53.8% growth.
China Pharma Holdings Earnings Reports & History FAQ
What were China Pharma Holdings's earnings last quarter?
China Pharma Holdings (NYSEMKT: CPHI) reported Q4 2024 earnings per share (EPS) of -$0.40, up 100% year over year. Total CPHI earnings for the quarter were -$1.22 million. In the same quarter last year, China Pharma Holdings's earnings per share (EPS) was -$0.20.
Is China Pharma Holdings profitable or losing money?
As of the last China Pharma Holdings earnings report, China Pharma Holdings is currently losing money. China Pharma Holdings's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$4.74 million, a 53.84% increase year over year.
What was CPHI's earnings growth in the past year?
As of China Pharma Holdings's earnings date in Q2 2025, China Pharma Holdings's earnings has grown year over year. CPHI earnings in the past year totalled -$4.74 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.